Related Experiment Videos
Successful treatment of cystoid macular edema with valdecoxib
Alexander Reis1, Florian Birnbaum, Lutz L Hansen
1Eye Clinic, University of Freiburg, Freiburg, Germany. reis@augenwerk.li
Purpose:
To evaluate the safety and efficacy of the COX-2 inhibitor valdecoxib in treating macular edema after cataract surgery.
Setting:
University Eye Clinic, Freiburg, Germany and Reis Medical Institution, Liechtenstein.
Methods:
The COX-2 inhibitor valdecoxib (Bextra) was administered systemically to patients with significant visual loss resulting from macular edema in a prospective clinical trial.
Results:
Ten patients were enrolled. Valdecoxib was tolerated well and led to a significant visual improvement within 10 days of therapy in all patients.
Conclusion:
The fast and persistent control of macular edema with valdecoxib warrants further investigation.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Ulcerative Colitis in IBD
Cerebral Edema ll: Pathophysiology
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...